Katherine Byrd, Ph.D. - Publications
Affiliations: | 2015- | Chemistry | University of Kansas, Lawrence, KS, United States |
Website:
http://medchem.ku.edu/lucas-francoYear | Citation | Score | |||
---|---|---|---|---|---|
2023 | Merfeld T, Peng S, Keegan BM, Crowley VM, Brackett CM, Gutierrez A, McCann NR, Reynolds TS, Rhodes MC, Byrd KM, Deng J, Matts RL, Blagg BSJ. Elucidation of novel TRAP1-Selective inhibitors that regulate mitochondrial processes. European Journal of Medicinal Chemistry. 258: 115531. PMID 37307624 DOI: 10.1016/j.ejmech.2023.115531 | 0.476 | |||
2018 | Byrd KM, Blagg BSJ. Chaperone substrate provides missing link for cancer drug discovery. The Journal of Biological Chemistry. 293: 2381-2382. PMID 29453286 DOI: 10.1074/jbc.H118.001591 | 0.466 | |||
2017 | Byrd K, Kent C, Blagg B. Synthesis and biological evaluation of stilbene analogs as Hsp90 C-terminal inhibitors. Chemmedchem. PMID 29058824 DOI: 10.1002/cmdc.201700630 | 0.47 | |||
2016 | Byrd KM, Subramanian C, Sanchez J, Motiwala HF, Liu W, Cohen MS, Holzbeierlein J, Blagg BS. Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 27037933 DOI: 10.1002/chem.201504955 | 0.484 | |||
2015 | Byrd KM, Arieno MD, Kennelly ME, Estiu G, Wiest O, Helquist P. Design and synthesis of a crosslinker for studying intracellular steroid trafficking pathways. Bioorganic & Medicinal Chemistry. 23: 3843-51. PMID 25890696 DOI: 10.1016/J.Bmc.2015.03.053 | 0.412 | |||
2011 | Cosner CC, Cabrera PJ, Byrd KM, Thomas AM, Helquist P. Selective oxidation of benzylic and allylic alcohols using Mn(OAc)3/catalytic 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. Organic Letters. 13: 2071-3. PMID 21395252 DOI: 10.1021/Ol200441G | 0.475 | |||
Show low-probability matches. |